UNSPSC 50501516: Ergocalciferol

This classification denotes a vitamin d with the molecular formula C28H44O, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier VS041H42XC, chemically known as 9,10-secoergosta-5,7,10(19),22-tetraen-3-ol, (3beta,5z,7e,22e)- but more generally known as ergocalciferol, which bears U.S. National Institutes of Health Compound Identifier 5280793. European Medicines Agency schedules Ergocalciferol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06596MIG.

The term ERGOCALCIFEROL is an International Non-Proprietary Name. World Health Organization schedules ergocalciferol in its Anatomical Therapeutic Chemical (ATC) Classification and its WHO-DD or Drug Dictionary. ERGOCALCIFEROL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

UNSPSC 50501516 Ergocalciferol, a Commodity code, covers the procurement of vitamin D2 (ergocalciferol) in pharmaceutical or nutritional supplement form by state and local health departments, school districts, and correctional facilities. State and local governments acquire ergocalciferol primarily for population health initiatives, dietary supplementation programs for vulnerable populations such as incarcerated individuals or students in resource-limited districts, and institutional medical supply chains. The code encompasses both bulk powder and finished dosage forms (tablets, capsules, liquids) when procured for government distribution or use rather than commercial resale.

The source provides no recent state or local contract opportunities tagged to this code as of July 2026, and therefore does not support characterization of active issuing bodies, geographic concentration, or representative solicitations under UNSPSC 50501516.